Pomdoctor Limited Reports 16.2% Net Revenue Growth for H1 FY2025, Expects Continued Growth Amidst Challenging Environment
ByAinvest
Wednesday, Dec 3, 2025 4:20 pm ET1min read
POM--
Pomdoctor Limited, a leading online medical services platform in China, reported a 16.2% increase in net revenue to RMB174.5 million ($24.4 million) for the six months ended June 30, 2025. Gross profit increased 16.3% to RMB28.3 million ($4.0 million), while gross profit margin remained stable at 16.2%. The company maintained strict cost controls and operational discipline despite a challenging macroeconomic environment and intensified market competition.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet